These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 37550781)
1. The efficacy and safety of vonoprazan-amoxicillin dual therapy in eradicating Helicobacter pylori: a systematic review and meta-analysis. Feng JH; Cheng J; Lao YJ; Huang K; Mou JL; Hu F; Lin ML; Lin J Eur J Med Res; 2023 Aug; 28(1):272. PubMed ID: 37550781 [TBL] [Abstract][Full Text] [Related]
2. Vonoprazan-amoxicillin dual therapy for Zhou BG; Mei YZ; Jiang X; Zheng AJ; Ding YB Saudi J Gastroenterol; 2023; 29(6):347-357. PubMed ID: 37602635 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Vonoprazan and Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis. Zhang WL; Lin BS; Li YY; Ding YM; Han ZX; Ji R Digestion; 2023; 104(4):249-261. PubMed ID: 37015201 [TBL] [Abstract][Full Text] [Related]
4. Vonoprazan-based therapies versus PPI-based therapies in patients with H. pylori infection: Systematic review and meta-analyses of randomized controlled trials. Liu L; Shi H; Shi Y; Wang A; Guo N; Li F; Nahata MC Helicobacter; 2024; 29(3):e13094. PubMed ID: 38790090 [TBL] [Abstract][Full Text] [Related]
5. Vonoprazan and amoxicillin dual therapy as the first-line treatment of Helicobacter pylori infection: A systematic review and meta-analysis. Du RC; Hu YX; Ouyang Y; Ling LX; Xu JY; Sa R; Liu XS; Hong JB; Zhu Y; Lu NH; Hu Y Helicobacter; 2024; 29(1):e13039. PubMed ID: 38036941 [TBL] [Abstract][Full Text] [Related]
6. Amoxicillin-vonoprazan dual therapy for Helicobacter pylori eradication: A systematic review and meta-analysis. Ouyang Y; Wang M; Xu YL; Zhu Y; Lu NH; Hu Y J Gastroenterol Hepatol; 2022 Sep; 37(9):1666-1672. PubMed ID: 35716370 [TBL] [Abstract][Full Text] [Related]
7. Treatment of Kanu JE; Soldera J World J Gastroenterol; 2024 Mar; 30(9):1213-1223. PubMed ID: 38577188 [TBL] [Abstract][Full Text] [Related]
8. Clinical impact of vonoprazan-based dual therapy with amoxicillin for H. pylori infection in a treatment-naïve cohort of junior high school students in Japan. Gotoda T; Kusano C; Suzuki S; Horii T; Ichijima R; Ikehara H J Gastroenterol; 2020 Oct; 55(10):969-976. PubMed ID: 32666199 [TBL] [Abstract][Full Text] [Related]
9. Vonoprazan-amoxicillin dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori eradication: A systematic review and meta-analysis. Zhou BG; Jiang X; Ding YB; She Q; Li YY Helicobacter; 2024; 29(1):e13040. PubMed ID: 37983865 [TBL] [Abstract][Full Text] [Related]
11. Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial. Chey WD; Mégraud F; Laine L; López LJ; Hunt BJ; Howden CW Gastroenterology; 2022 Sep; 163(3):608-619. PubMed ID: 35679950 [TBL] [Abstract][Full Text] [Related]
12. Vonoprazan: A Review in Helicobacter pylori Infection. Shirley M Drugs; 2024 Mar; 84(3):319-327. PubMed ID: 38388872 [TBL] [Abstract][Full Text] [Related]
13. Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Suzuki S; Gotoda T; Kusano C; Ikehara H; Ichijima R; Ohyauchi M; Ito H; Kawamura M; Ogata Y; Ohtaka M; Nakahara M; Kawabe K Gut; 2020 Jun; 69(6):1019-1026. PubMed ID: 31915235 [TBL] [Abstract][Full Text] [Related]
14. Standard triple therapy for Helicobacter pylori infection in China: a meta-analysis. Wang B; Lv ZF; Wang YH; Wang H; Liu XQ; Xie Y; Zhou XJ World J Gastroenterol; 2014 Oct; 20(40):14973-85. PubMed ID: 25356059 [TBL] [Abstract][Full Text] [Related]
15. Lower impact of vonoprazan-amoxicillin dual therapy on gut microbiota for Helicobacter pylori eradication. Horii T; Suzuki S; Takano C; Shibuya H; Ichijima R; Kusano C; Ikehara H; Gotoda T J Gastroenterol Hepatol; 2021 Dec; 36(12):3314-3321. PubMed ID: 34107551 [TBL] [Abstract][Full Text] [Related]
16. Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication. Jung YS; Kim EH; Park CH Aliment Pharmacol Ther; 2017 Jul; 46(2):106-114. PubMed ID: 28497487 [TBL] [Abstract][Full Text] [Related]
17. Low-dose or high-dose amoxicillin in vonoprazan-based dual therapy for Helicobacter pylori eradication? A systematic review and meta-analysis. Ju KP; Kong QZ; Li YY; Li YQ Helicobacter; 2024; 29(1):e13054. PubMed ID: 38900537 [TBL] [Abstract][Full Text] [Related]
18. Vonoprazan With Amoxicillin or Amoxicillin and Clarithromycin for the Treatment of Liu L; Nahata MC Ann Pharmacother; 2023 Oct; 57(10):1185-1197. PubMed ID: 36688309 [TBL] [Abstract][Full Text] [Related]
19. Clinical trial: seven-day vonoprazan- versus 14-day proton pump inhibitor-based triple therapy for first-line Helicobacter pylori eradication. Ang D; Koo SH; Chan YH; Tan TY; Soon GH; Tan CK; Lin KW; Krishnasamy-Balasubramanian JK; Wong YJ; Kumar R; R R; Tan Y; Ong PJ; Tan YJ; Li JW; Kwek AB; Ang TL Aliment Pharmacol Ther; 2022 Aug; 56(3):436-449. PubMed ID: 35665947 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of vonoprazan-based regimen for Helicobacter pylori eradication: A meta-analysis of randomized clinical trials. Yang C; Li S; Huang T; Lin H; Jiang Z; He Y; Yuan J; An H J Clin Pharm Ther; 2022 Jul; 47(7):897-904. PubMed ID: 35247003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]